Pure Global AI
NCT06103136Recruiting

Maestro 1.0 Post-Market Registry

Moon SurgicalClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Surgery
Drug/Device/Intervention
Laparoscopic surgery using the Maestro Platform
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Moon Surgical
Location
Besançon,Saint-Laurent-du-Var, France
Timeline & enrollment
Phase
N/A
Start date
Sep 29, 2023
End date
Apr 01, 2024
Enrollment
400 participants
Primary outcome

Adverse Events (AEs) in terms of type (device/procedure related), seriousness, level of severity. Rate of occurence of intra-procedural and post-procedural adverse events, and device related complications,Completion of the procedure using the Maestro Platform without conversion to a manual minimally invasive or open surgical procedure specifically due to a device failure or malfunction

Summary

The objective of the study is to observe the real-life usage of the Maestro Platform for
 surgical assistance in laparoscopic surgery.

ICD-10 classifications
Other surgical proceduresSurgical procedure, unspecifiedDuring surgical operationDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06103136
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06103136 through Pure Global AI's free database. This phase not specified trial is sponsored by Moon Surgical and is currently Recruiting. The study focuses on Surgery. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.